A diverse site network for novel pediatric, adolescent, and maternal product development programs
Velocity provides access to region-leading pediatric, family practice, and internal medicine clinics across the U.S. The Velocity network also includes obstetricians and pediatric neurologists, as well as leading vaccine investigators that are highly sought after for maternal immunization trials.
At its pediatric sites, OB-GYN sites, and dedicated research centers, Velocity frequently conducts studies involving newborns, fetal health, and pregnant subjects. Paired with access to diverse patient populations, this broad expertise supports thorough assessment of disease presentation and therapeutic response.
For trials in which long-term care and assessment through developmental stages is critical, Velocity’s partnership with well-established pediatricians supports rapid patient identification and strong retention. In-house quality assurance teams and full-time staff at each site ensure accurate data collection and uncompromising care for the vulnerable pediatric population.
- Atopic dermatitis
- COVID-19 vaccine
- H5N1, H1N1 influenza vaccine
- HPV vaccine
- Human metapneumovirus (HMPV) vaccine
- Infant formula
- Influenza treatment
- Lyme disease
- Maternal vaccines
- Measles, mumps, and rubella vaccine
- Meningococcal vaccine
- Molluscum contagiosum
- Multiple sclerosis
- On- and off-season influenza vaccine
- Parainfluenza virus vaccine
- Pneumococcal vaccine
- RSV vaccine
- Tetanus, diphtheria, pertussis (Tdap) vaccine
- Tourette syndrome